Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its audited results for the year ended 31 December 2025.  The Group reported revenue growth of 7% (6% in constant currency) to $3.349 billion, compared to $3.127 billion in 2024 with growth in all three geographies, North America, MENA, and Europe.  Said Darwazah, […] The post Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes appeared first on Web-Release.

    Thumbay Group has signed a landmark Memorandum of Understanding (MoU) with the Geneva College of Longevity Science (GCLS), Switzerland, becoming the first private medical university in the United Arab Emirates… The post Thumbay to Launch UAE’s First-of-Its-Kind Academic Programs in Longevity Medicine in Partnership with Switzerland’s Geneva College of Longevity Science appeared first on Web-Release.